[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Genmab A/S (GNMSF)

Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 20,810,656
  • Shares Outstanding, K 61,570
  • Annual Sales, $ 3,720 M
  • Annual Income, $ 963,000 K
  • EBIT $ 1,257 M
  • EBITDA $ 1,328 M
  • 60-Month Beta 0.77
  • Price/Sales 5.58
  • Price/Cash Flow 21.60
  • Price/Book 3.49
  • Price/Earnings ttm 24.12
  • Earnings Per Share ttm 13.97
  • Most Recent Earnings $5.42 on 08/06/26
  • Next Earnings Date 11/05/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
282.0000 +19.86%
on 08/03/26
338.0000 unch
on 08/27/26
+52.0000 (+18.18%)
since 07/27/26
3-Month
232.3401 +45.48%
on 06/02/26
338.0000 unch
on 08/27/26
+78.0000 (+30.00%)
since 05/26/26
52-Week
232.3401 +45.48%
on 06/02/26
352.0000 -3.98%
on 01/14/26
+96.1625 (+39.76%)
since 08/26/25

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 345.1533
2nd Resistance Point 341.5767
1st Resistance Point 339.7883
Last Price 338.0000
1st Support Level 334.4233
2nd Support Level 330.8467
3rd Support Level 329.0583

See More

52-Week High 352.0000
Last Price 338.0000
Fibonacci 61.8% 306.2899
Fibonacci 50% 292.1700
Fibonacci 38.2% 278.0502
52-Week Low 232.3401

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.